NHNada El Husseini

Nada El Husseini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nada El Husseini has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Stroke Risk After Bioprosthetic Aortic Valve Replacement in Aortic Stenosis: Systematic Review and Meta-Analysis

    by Tarek Bou Dargham, Sara Hassani, Brian Mac Grory, Melissa A. Daubert, Dylan Ryan, Tracy Truong, Mohamad B. Moumneh, Samantha J. Kaplan, Wuwei Feng, Nada El Husseini

    BACKGROUND: Stroke is a possible complication after bioprosthetic aortic valve replacement (AVR) for severe aortic stenosis (AS), impacting morbidity and mortality. Accurate estimates of the proportion of individuals who experience stroke within and beyond the periprocedural period after transcatheter AVR (TAVR), surgical AVR, and valve-in-valve (ViV) replacement are essential for management and prognostication. The objective was to determine the proportion of adults aged >18 who experienced an ischemic stroke after bioprosthetic AVR for AS. METHODS: A systematic search of MEDLINE, Embase, and Web of Science was conducted from database inception through March 2024. Studies reporting on stroke rates at least 90 days after bioprosthetic AVR for severe AS, including ViV procedures, and meeting predefined eligibility criteria were included. The pooled proportion of individuals experiencing a stroke was estimated for TAVR and ViV procedures, whereas comparative analyses between TAVR and surgical AVR were performed using mixed-effects models in studies directly comparing both procedures. RESULTS: Twenty-seven studies were included in the native AS treatment cohort, and 5 in the ViV subanalysis. In native AS, the pooled 30-day proportion of individuals who had a stroke after TAVR was 3.0% (95% CI, 2.5–3.9), with different studies reporting major and minor stroke proportions of 1.7% each. At 1 year, all stroke proportion was 5.0% (95% CI, 4.0–6.0), major stroke was 3.0%, and minor stroke was 2.0%. Comparative analysis demonstrated that TAVR was associated with significantly lower odds of all stroke at 30 days compared with surgical AVR (odds ratio, 0.73 [95% CI, 0.57–0.93]). No significant difference in the proportions of individuals who had a stroke was observed in TAVR versus surgical AVR at 1, 2, or 5 years. In the ViV cohort, the pooled 30-day and 1-year all stroke proportion after ViV was 2.0% (95% CI, 1.0–3.0) and 3.0% (95% CI, 2.0–6.0), respectively. CONCLUSIONS: This meta-analysis provides updated estimates of stroke after bioprosthetic AVR for AS, capturing risk beyond the early periprocedural period. Future studies should investigate the causes of long-term stroke post-AVR, the effects of different antithrombotic therapies on the risk of stroke, as well as the potential impact of these procedures on short and long-term cognitive function.


  • Open Access

    Improving Access to Primordial and Primary Stroke Prevention: Global Considerations

    by Nada El Husseini, Michelle Nichols, Mayowa Owolabi

    Stroke is the second‐leading cause of death and the third‐leading cause of disability worldwide. Low‐ and middle‐income countries continue to experience an increase in stroke incidence despite scientific advances to prevent strokes. In this topical review, we provide an overview of primordial and primary prevention strategies and present actionable practices that may improve access to stroke prevention including policies and population‐wide strategies, such as task‐shifting and sharing and health system reengineering. Most strokes can be prevented through primordial prevention defined as the avoidance of the emergence of risk factors and primary prevention defined as effective management of risk factors. Primordial and primary stroke prevention strategies are predominantly behavioral (eg, smoking and recreational drug avoidance or cessation, physical activity, healthy diet) and pharmacological (eg, medications that control risk factors such as diabetes, hypertension, or cholesterol). However, access to primordial and primary stroke prevention is variable and affected by multiple social and commercial determinants of the health of individuals as well as the environments in which they live, cultural considerations, and the policies that govern these environments. In light of emerging novel risk factors such as mental stressors, air pollutants, diet types, and risk factors specific to women, additional societal, individual, health care professionals, funders, and health system efforts should be mobilized for equitable and effective implementation of stroke prevention.


  • Frequency, Risk Factors, and Outcomes of Strokes in Patients With Primary Glioma After Cranial Radiation Therapy

    by Dylan Ryan, Megumi Sugita, Gloria Broadwater, Eric Lipp, Katherine B. Peters, Nada El Husseini

    Radiation therapy is the mainstay of therapy for patients with glioma. While this treatment modality can improve survival, treatment-related complications may include radiation-induced vasculopathy and increased risk of stroke. We aimed to evaluate the stroke frequency, associated risk factors, and outcomes after cranial radiation therapy in patients with glioma. This is a retrospective cohort study at a single tertiary academic brain tumor center involving patients diagnosed with gliomas between 2005 and 2021 who received cranial radiation therapy. Data were collected from the time of cranial radiation therapy until last follow-up. Logistic regression analyses were used to evaluate the association of clinical and demographic variables with all-cause, ischemic, and hemorrhagic strokes. In a retrospective cohort of 930 patients, 910 received radiation therapy (mean age 53.8 years; 40% women) and were included in the final analysis. A total of 91 patients (10.0%) were diagnosed with stroke (73.6% ischemic; 15.4% with recurrent strokes). The median time to diagnosis of stroke after onset of radiation therapy was 652 days with median time to recurrent stroke of 102 days. In a univariable model, Black race (odds ratio [OR] 3.83, 95% CI 1.94-7.56), radiation necrosis (OR 4.62, 95% CI 2.02-10.55), hypertension (OR 1.93, 95% CI 1.23-3.01), hyperlipidemia (OR 5.93, 95% CI 3.61-9.57), and diabetes mellitus (OR 2.25, 95% CI 1.28-3.95) were associated with higher odds of all-cause stroke. In multivariable analysis, Black race (OR 3.41, 95% CI 1.59-7.33), radiation necrosis (OR 6.42, 95% CI 2.45-16.79), and hyperlipidemia (OR 6.42, 95% CI 3.91-10.57) were significantly associated with increased odds of all-cause stroke. Radiation necrosis and hyperlipidemia were associated with increased odds of ischemic stroke. Black race, hyperlipidemia, and younger age were associated with increased odds of hemorrhagic stroke. Compared with ischemic strokes, hemorrhagic strokes were associated with higher poststroke disability. In a large, retrospective cohort of adult patients with glioma treated with cranial radiation therapy, 1 in 10 patients were subsequently diagnosed with stroke with 15.4% suffering recurrent strokes. Factors associated with increased odds of stroke included Black race, radiation necrosis, and hyperlipidemia and should be validated in future prospective cohorts. Study limitations include the retrospective design, incomplete stroke workups, and lack of molecular diagnostics.


  • MRI Predictors of Cognitive Function After Lacunar Infarction

    by Sara Hassani, Deborah Koltai, Timothy J. Amrhein, Shakthi Unnithan, Hussein Al-Khalidi, Cheryl D. Bushnell, Larry B. Goldstein, Nada El Husseini

    BACKGROUND: Poststroke cognitive impairment is associated with disability and decreased quality of life. We assessed whether individual or collective magnetic resonance imaging (MRI) biomarkers can aid in predicting cognitive impairment after lacunar infarction (LACI). METHODS: We conducted a retrospective analysis of data from the American Stroke Association Bugher Small Vessel Study, which included 134 patients within 2 years of an acute LACI, enrolled between 2007 and 2012 at 4 North Carolina hospitals. MRI brain measures at the time of the stroke included as follows: 1, total number of LACIs (index LACI and nonindex radiographic lacunes); 2, size of the largest lacune; 3, ventricular size; 4, cerebral atrophy; 5, radiographic locations (supratentorial, infratentorial, or both); and 6, white matter disease (WMD) extent. WMD extent, cerebral atrophy, and ventricular size were graded using the CHS (Cardiovascular Health Study) scores. The primary outcomes were as follows: 1, total score on Short-Form Montreal Cognitive Assessment to assess global cognition; and 2, time to complete TRAIL Making Test Part B (TMT-B) to evaluate executive function. Regression analyses were used to assess the association between the 6 MRI measures and cognitive function adjusting for demographic and clinical variables. RESULTS: One hundred thirty-four participants completed Short-Form Montreal Cognitive Assessment testing and 100 completed TMT-B at a mean of 76.5 (SD, 172.7) days from the index LACI. There were no associations between MRI characteristics and Short-Form Montreal Cognitive Assessment. On univariable analyses, cerebral atrophy (β=35 [95% CI, 14.17–55.83]; P =0.0010), ventricular size (β=40.1 [95% CI, 22.24–57.96]; P P P <0.0001). In adjusted models after performing variable selection, the extent of WMD remained the only MRI measure associated with TMT-B time. CONCLUSIONS: Among the assessed MRI measures, only the extent of WMD was independently associated with executive function after LACI.


  • Ischemic Stroke in Immune-Mediated Thrombotic Thrombocytopenia Purpura: Diagnostic and Management Challenges

    by Allison O. Taylor, Alexandre Soares Ferreira Junior, Braydon L. Dymm, Wuwei Feng, Nada El Husseini, Oluwatoyosi A. Onwuemene


  • The hypereosinophilic syndrome - an unusual cause of myocarditis and cardioembolic strokes

    by Dylan Ryan, Ovais Inamullah, Nada El Husseini, Endi Wang, M. Angelica Selim, Wuwei Feng